Psychiatry’s next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders
Journal of Psychopharmacology June 19, 2013 Rl Carhart-Harris, Stefan Brugger, Dj Nutt et al. 43 citations
Despite the widespread application of drug modelling in psychiatric research, the relative value of different models has never been formally compared in the same analysis. Here we compared the effects of five drugs (cannabis, psilocybin, amphetamine, ketamine and alcohol) in relation to psychiatric symptoms in a two-part subjective analysis. In the first part, mental health professionals...